PlainRecalls
FDA Drug Moderate Class II Terminated

Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.

Reported: February 23, 2022 Initiated: February 15, 2022 #D-0568-2022

Product Description

Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.

Reason for Recall

cGMP Deviations

Details

Recalling Firm
ANI Pharmaceuticals, Inc.
Units Affected
5,477 bottles
Distribution
Nationwide within the United States
Location
Baudette, MN

Frequently Asked Questions

What product was recalled?
Pyrazinamide Tablets, USP 500 mg, 100-count bottles, Rx only, Manufactured by: ULTRAtab Laboratories, Inc. Highland, NY 12528, Distributed by Par Pharmaceuticals, Chestnut Ridge, NY 10977, NDC 67253-660-10.. Recalled by ANI Pharmaceuticals, Inc.. Units affected: 5,477 bottles.
Why was this product recalled?
cGMP Deviations
Which agency issued this recall?
This recall was issued by the FDA Drug on February 23, 2022. Severity: Moderate. Recall number: D-0568-2022.